Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Oxford BioMedica acquires anticancer macrophage technology

May 2, 1997

Emisphere receives notices of allowance for oral delivery technologies

April 28, 1997

LifeCell issued U.S. patent for ThromboSol blood platelet preservation product

April 28, 1997

Biosource awarded grant for human therapeutic protein production

April 25, 1997

Avigen granted patent on high-yield AAV production for gene therapy

April 24, 1997

Hybridon issued patent for pent-enoyl-protected nucleotides

April 23, 1997

Oncor's Sunrise Amplification Detection System presented

April 23, 1997

Genetronics develops electroporation therapy drug delivery system

April 23, 1997

AntiCancer receives grant for development of mouse cancer model

April 21, 1997

Ribozyme and Schering AG to collaborate on target validation and therapeutic development

April 21, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...